<DOC>
	<DOC>NCT00312182</DOC>
	<brief_summary>To assess if nelfinavir has any clinically meaninful effect on cardiac function, namely ECG evaluation</brief_summary>
	<brief_title>Thorough QT Study of Nelfinavir</brief_title>
	<detailed_description />
	<mesh_term>Nelfinavir</mesh_term>
	<criteria>Healthy male and female subjects between the ages of 18 and 55 years, inclusive. Body Mass Index (BMI) of approximately 18 to 30 kg/m2. Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>